Cytosolix

Tolland, United States

Cytosolix develops novel oral and IV derivatives that target tumor acidity to improve the efficacy of small molecule cancer therapeutics.

$6.6M raised

Jun 2023

Venture - Series Unknown

Top Investors

Connecticut Innovations

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cytosolix raised?

Cytosolix has raised $6.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2023.

Who are Cytosolix's investors?

Cytosolix's investors include Connecticut Innovations.

Where is Cytosolix headquartered?

Cytosolix is headquartered in Tolland, United States.

What does Cytosolix do?

Cytosolix develops novel oral and IV derivatives that target tumor acidity to improve the efficacy of small molecule cancer therapeutics.

What stage is Cytosolix at?

Cytosolix is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 28, 2023.

MLA

"Cytosolix — Funding & Investors." VCBacked, June 28, 2023, https://www.vcbacked.co/company/cytosolix. Accessed June 4, 2026.

APA

VCBacked. (2023). Cytosolix — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/cytosolix

Wikipedia (cite web)

{{cite web |title=Cytosolix — Funding & Investors |url=https://www.vcbacked.co/company/cytosolix |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 28, 2023.